- Home
- CLSD vs NCSM Comparison
CLSD vs NCSM Comparison
Compare CLSD & NCSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLSD
- NCSM
- Stock Information
- Founded
- CLSD 2011
- NCSM 2006
- Country
- CLSD United States
- NCSM United States
- Employees
- CLSD N/A
- NCSM N/A
- Industry
- CLSD Biotechnology: Pharmaceutical Preparations
- NCSM Oilfield Services/Equipment
- Sector
- CLSD Health Care
- NCSM Energy
- Exchange
- CLSD Nasdaq
- NCSM Nasdaq
- Market Cap
- CLSD 74.3M
- NCSM 68.4M
- IPO Year
- CLSD 2016
- NCSM 2017
- Fundamental
- Price
- CLSD $0.93
- NCSM $29.45
- Analyst Decision
- CLSD Strong Buy
- NCSM
- Analyst Count
- CLSD 6
- NCSM 0
- Target Price
- CLSD $5.33
- NCSM N/A
- AVG Volume (30 Days)
- CLSD 301.0K
- NCSM 10.4K
- Earning Date
- CLSD 03-11-2025
- NCSM 03-06-2025
- Dividend Yield
- CLSD N/A
- NCSM N/A
- EPS Growth
- CLSD N/A
- NCSM N/A
- EPS
- CLSD N/A
- NCSM 16.77
- Revenue
- CLSD $7,703,000.00
- NCSM $152,801,000.00
- Revenue This Year
- CLSD N/A
- NCSM $13.26
- Revenue Next Year
- CLSD $91.87
- NCSM $6.32
- P/E Ratio
- CLSD N/A
- NCSM $1.76
- Revenue Growth
- CLSD 248.39
- NCSM 3.66
- 52 Week Low
- CLSD $0.80
- NCSM $14.73
- 52 Week High
- CLSD $2.12
- NCSM $30.44
- Technical
- Relative Strength Index (RSI)
- CLSD 42.76
- NCSM 63.99
- Support Level
- CLSD $0.90
- NCSM $27.10
- Resistance Level
- CLSD $0.97
- NCSM $29.67
- Average True Range (ATR)
- CLSD 0.05
- NCSM 1.25
- MACD
- CLSD 0.00
- NCSM 0.09
- Stochastic Oscillator
- CLSD 24.29
- NCSM 84.01
About CLSD Clearside Biomedical Inc.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.
About NCSM NCS Multistage Holdings Inc.
NCS Multistage Holdings Inc provides products and support services that facilitate the optimization of oil and natural gas well completions and field development strategies. NCS provides its products and services to exploration and production companies for use in onshore wells, predominantly wells that have been drilled with horizontal laterals in unconventional oil and natural gas formations. The company's primary offering is its fracturing systems products and services, which enable efficient pinpoint stimulation: the process of individually stimulating each entry point into a formation targeted by an oil or natural gas well. Geographically, majority of revenue is generated from United States.